Mark R. Kelley, the Betty and Earl Herr professor of pediatric oncology research at the Indiana University School of Medicine and associate director of basic science at the IU Melvin and Bren Simon Comprehensive Cancer Center, is celebrating the positive Phase 2 trial results of a first-of-its-kind drug he developed to slow the progression of… Read more »